CMAJ September 9, 2008; 179 (6).
First published September 1, 2008; doi:10.1503/cmaj.080916
© 2008 Canadian Medical Association or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
Anaphylaxis following quadrivalent human papillomavirus vaccination
Julia M.L. Brotherton, MD MPH,
Mike S. Gold, MD,
Andrew S. Kemp, MD PhD,
Peter B. McIntyre, MD PhD,
Margaret A. Burgess, MD,
Sue Campbell-Lloyd, RN on behalf of the New South Wales Health HPV Adverse Events Panel
From the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (Brotherton, McIntyre, Burgess), The Children's Hospital at Westmead, and the University of Sydney, New South Wales; the Department of Paediatrics (Gold), Women's and Children's Hospital, Adelaide, South Australia; Department of Allergy and Immunology (Kemp), The Children's Hospital at Westmead; Discipline of Paediatrics and Child Health (Kemp, Burgess), University of Sydney, New South Wales; and the New South Wales Department of Health (Campbell-Lloyd), North Sydney, New South Wales, Australia